MedPath

Hill Dermaceuticals, Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

4

Active:0
Completed:2

Trial Phases

3 Phases

Phase 1:1
Phase 2:2
Phase 3:1

Drug Approvals

1

FDA:1

Drug Approvals

TOLAK

Approval Date
Sep 6, 2022
FDA

Clinical Trials

Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials

Phase 2
2 (50.0%)
Phase 1
1 (25.0%)
Phase 3
1 (25.0%)

Phase III Efficacy and Safety Study of Miconazole Oil for Otomycosis

Phase 3
Recruiting
Conditions
Otomycosis
Interventions
First Posted Date
2022-12-21
Last Posted Date
2024-01-17
Lead Sponsor
Hill Dermaceuticals, Inc.
Target Recruit Count
100
Registration Number
NCT05660382
Locations
🇺🇸

Charleston ENT Associates, LLC, North Charleston, South Carolina, United States

🇺🇸

Head and Neck Surgery Specialist, Chula Vista, California, United States

🇺🇸

Advanced ENT & Allergy, Louisville, Kentucky, United States

and more 4 locations

Efficacy and Safety Study of Miconazole Oil Versus Vehicle on Fungal Infection of the Ear Canal (Otomycosis)

Phase 2
Completed
Conditions
Otomycosis
Interventions
Drug: vehicle oil
First Posted Date
2020-06-16
Last Posted Date
2024-01-19
Lead Sponsor
Hill Dermaceuticals, Inc.
Target Recruit Count
382
Registration Number
NCT04432376
Locations
🇺🇸

Head and Neck Surgery Specialists, Chula Vista, California, United States

🇺🇸

UCSD, La Jolla, California, United States

🇺🇸

DaVinci Research, LLC, Roseville, California, United States

and more 9 locations

Clobetasol Topical Oil for Children With Moderate to Severe Atopic Dermatitis

Phase 1
Terminated
Conditions
Atopic Dermatitis
Interventions
First Posted Date
2019-02-20
Last Posted Date
2021-06-23
Lead Sponsor
Hill Dermaceuticals, Inc.
Target Recruit Count
8
Registration Number
NCT03847389
Locations
🇺🇸

International Clinical Research - US, LLC, Sanford, Florida, United States

🇺🇸

AeroAllergy Research Laboratories of Savannah, Inc, Savannah, Georgia, United States

🇺🇸

Paddington Testing Co., Inc., Philadelphia, Pennsylvania, United States

and more 3 locations

Dose-Ranging Study for Miconazole Oil for Treatment of Otomycosis

Phase 2
Completed
Conditions
Otomycosis
Interventions
Drug: 7-Day Miconazole Oil (Miconazole 2%)
Drug: 14-Day Miconazole Oil (Miconazole 2%)
Drug: 14-Day Placebo - Oil Vehicle
First Posted Date
2017-04-26
Last Posted Date
2022-10-05
Lead Sponsor
Hill Dermaceuticals, Inc.
Target Recruit Count
65
Registration Number
NCT03130738
Locations
🇺🇸

Head and Neck Surgery Specialist, Chula Vista, California, United States

🇺🇸

University of California San Diego, La Jolla, California, United States

🇺🇸

Ear Nose and Throat Associates of Southe Florida, Boynton Beach, Florida, United States

and more 3 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.